Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1940272 AUSTIN, TX
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,795,531
+$1,053,695 QoQ
Shares Held
191,869
+108.9% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#62
of 242 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2025
CallValue
$2,128,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. SMMT ranks #100 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in SMMT

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,795,531 191,869
2026-03-31 $1,741,836 91,869
2025-12-31 $1,606,788 91,869
2025-09-30 $2,127,339 102,969
2025-06-30 $255,360 12,000
2025-06-30 $2,128,000 100,000
2025-03-31 $1,929,000 100,000